The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Dr Vanita Aroda is Director of Diabetes Clinical Research at the Brigham and Women’s Hospital in Boston, MA, and is Associate Professor of Medicine at Harvard Medical School. Dr Aroda completed her training in internal medicine and in endocrinology, diabetes and metabolism at the University of California San Diego, CA, USA.
Dr Aroda has an interest and published record in diabetes prevention and novel therapeutics in diabetes and weight management. She also has a strong interest in understanding therapeutic interventions in large multicentre clinical trials and their applicability and integration into care. Dr Aroda has years of experience in clinical trial conduct and leadership, has served as an investigator on the National Institutes of Health-funded GRADE, D2d and DPPOS studies, and as the national or international signatory Principal Investigator for multiple therapeutic clinical trials. Dr Aroda serves on the Professional Practice Committee of the American Diabetes Association.